These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24228554)

  • 1. [Research progress of Chinese medicine treatment of HAART-related hyperlipidemia].
    Xian QF; Liu Y; Zou W; Wang J
    Zhongguo Zhong Yao Za Zhi; 2013 Aug; 38(15):2530-3. PubMed ID: 24228554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research progress of Chinese medicine treatment of HAART-related toxic and side effect].
    Liu Y; Dong JP; Zou W; Gao GJ; Wang J
    Zhongguo Zhong Yao Za Zhi; 2013 Aug; 38(15):2527-9. PubMed ID: 24228553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HIV-infection, HAART (highly-active antiretroviral therapy) and hyperlipidemia].
    Hirsch HH; Battegay M
    Dtsch Med Wochenschr; 2003 May; 128(19):1051-4. PubMed ID: 12736856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multi-centered, randomized controlled clinical study on Chinese medicine formula particles for hyperlipidaemia associated with highly active antiretroviral therapy].
    Ni L; Wang RB; Guo HJ; Tan XH; Sun LJ; Zheng YH; Duan CY; Hu DQ; Wang WJ; Wang YG; Zhao HX
    Zhongguo Zhong Yao Za Zhi; 2013 Aug; 38(15):2443-7. PubMed ID: 24228532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Safety study of 52-week highly active antiretroviral therapy in 198 HIV/AIDS Chinese patients].
    Li WJ; Dai Y; Han Y; Qiu ZF; Xie J; Zuo LY; Li YL; Li TS
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(19):1318-22. PubMed ID: 21756757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Side effects of antiretroviral therapy].
    Teodor A; Teodor D; Luca V
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):23-6. PubMed ID: 15688751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolic syndrome, an epidemic among HIV-infected patients on HAART.
    Jevtović DJ; Dragović G; Salemović D; Ranin J; Djurković-Djaković O
    Biomed Pharmacother; 2009 Jun; 63(5):337-42. PubMed ID: 18996676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of lipid elevations associated with the treatment of patients with HIV infection.
    Piliero PJ
    MedGenMed; 2003 Jun; 5(2):1. PubMed ID: 14603100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretrovirals and cardiovascular disease: is HAART bad for your heart?
    Fichtenbaum CJ
    AIDS Clin Care; 2003 Aug; 15(8):69-73, 76. PubMed ID: 12945527
    [No Abstract]   [Full Text] [Related]  

  • 11. Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients.
    Calza L; Manfredi R; Chiodo F
    J Antimicrob Chemother; 2004 Jan; 53(1):10-4. PubMed ID: 14645323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV and hyperlipidemia: current recommendations and treatment.
    Capili B; Anastasi JK
    Medsurg Nurs; 2006 Feb; 15(1):14-9, 35; quiz 20. PubMed ID: 16583530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV and cardiovascular risk factors.
    Falusi OM; Aberg JA
    AIDS Read; 2001 May; 11(5):263-8. PubMed ID: 11392695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of switch to atazanavir-containing combination antiretroviral therapy in HIV-1-infected patients with hyperlipidemia.
    Lu CL; Lin YH; Wong WW; Lin HH; Ho MW; Wang NC; Hsieh SM; Sheng WH; Hung CC; Chen MY
    J Microbiol Immunol Infect; 2011 Aug; 44(4):258-64. PubMed ID: 21524961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitigation of antiretroviral-induced hyperlipidemia by hepatitis C virus co-infection.
    Cooper CL; Mills E; Angel JB
    AIDS; 2007 Jan; 21(1):71-6. PubMed ID: 17148970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic disorders and lipodystrophy. Adverse effects of antiretroviral therapy].
    Goebel FD; Westner I
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():40-4. PubMed ID: 11373778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolic changes in PI-based HAART. Change to atazanavir: continued effectiveness with improved lipid profile].
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():42-3. PubMed ID: 19024917
    [No Abstract]   [Full Text] [Related]  

  • 18. Substituting abacavir for hyperlipidemia-associated protease inhibitors in HAART regimens improves fasting lipid profiles, maintains virologic suppression, and simplifies treatment.
    Keiser PH; Sension MG; DeJesus E; Rodriguez A; Olliffe JF; Williams VC; Wakeford JH; Snidow JW; Shachoy-Clark AD; Fleming JW; Pakes GE; Hernandez JE;
    BMC Infect Dis; 2005 Jan; 5():2. PubMed ID: 15647105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperlipidemia in HIV-infected patients: the protective effect of hepatitis C virus co-infection.
    Collazos J; Mayo J; Ibarra S; Cazallas J
    AIDS; 2003 Apr; 17(6):927-9. PubMed ID: 12660545
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiovascular disease and toxicities related to HIV infection and its therapies.
    Zareba KM; Miller TL; Lipshultz SE
    Expert Opin Drug Saf; 2005 Nov; 4(6):1017-25. PubMed ID: 16255661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.